Vitamin D deficiency is associated with high levels of HBV replication, high Child-Pugh scores, poor adverse clinical outcomes and poor response to Peg-IFN therapy (Farnik et al., 2013; Chen et al., 2015; Zhao et al., 2016; Yu et al., 2017). This evidence concerns the gene IFNA1 and vitamin D deficiency.